AU2011275695B2 - Dry compositions and devices containing such dry compositions for use in photodynamic therapy or photodynamic diagnosis - Google Patents

Dry compositions and devices containing such dry compositions for use in photodynamic therapy or photodynamic diagnosis Download PDF

Info

Publication number
AU2011275695B2
AU2011275695B2 AU2011275695A AU2011275695A AU2011275695B2 AU 2011275695 B2 AU2011275695 B2 AU 2011275695B2 AU 2011275695 A AU2011275695 A AU 2011275695A AU 2011275695 A AU2011275695 A AU 2011275695A AU 2011275695 B2 AU2011275695 B2 AU 2011275695B2
Authority
AU
Australia
Prior art keywords
pharmaceutical composition
ala
irradiation device
dry pharmaceutical
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2011275695A
Other languages
English (en)
Other versions
AU2011275695A1 (en
Inventor
Bjorn Klem
Norbert Lange
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Photocure ASA
Original Assignee
Photocure ASA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Photocure ASA filed Critical Photocure ASA
Publication of AU2011275695A1 publication Critical patent/AU2011275695A1/en
Application granted granted Critical
Publication of AU2011275695B2 publication Critical patent/AU2011275695B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0061—5-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0036—Porphyrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0601—Apparatus for use inside the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/062—Photodynamic therapy, i.e. excitation of an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Radiation-Therapy Devices (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2011275695A 2010-07-09 2011-07-08 Dry compositions and devices containing such dry compositions for use in photodynamic therapy or photodynamic diagnosis Ceased AU2011275695B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10251232 2010-07-09
EP10251232.4 2010-07-09
PCT/EP2011/061688 WO2012004399A1 (en) 2010-07-09 2011-07-08 Dry compositions and devices containing such dry compositions for use in photodynamic therapy or photodynamic diagnosis

Publications (2)

Publication Number Publication Date
AU2011275695A1 AU2011275695A1 (en) 2013-02-14
AU2011275695B2 true AU2011275695B2 (en) 2014-07-31

Family

ID=44628087

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2011275695A Ceased AU2011275695B2 (en) 2010-07-09 2011-07-08 Dry compositions and devices containing such dry compositions for use in photodynamic therapy or photodynamic diagnosis

Country Status (9)

Country Link
US (1) US20130178787A1 (enExample)
EP (1) EP2590714B1 (enExample)
JP (1) JP5991970B2 (enExample)
KR (1) KR101842732B1 (enExample)
AU (1) AU2011275695B2 (enExample)
BR (1) BR112013000613A2 (enExample)
CA (1) CA2804337A1 (enExample)
ES (1) ES2620780T3 (enExample)
WO (1) WO2012004399A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140276107A1 (en) 2011-10-14 2014-09-18 Photocure Asa Photodynamic diagnosis
CN102670577B (zh) * 2012-05-18 2018-04-13 上海复旦张江生物医药股份有限公司 一种光敏剂组合物、其使用方法及用途
US20140067024A1 (en) 2012-08-30 2014-03-06 Photocure Asa Dual panel photodynamic therapy lamp
GB201221123D0 (en) 2012-11-23 2013-01-09 Photocure As Device for photodynamic treatment
GB201306369D0 (en) 2013-04-09 2013-05-22 Photocure As Irradiation device
WO2014204001A1 (ja) * 2013-06-21 2014-12-24 国立大学法人 岡山大学 異常活性化細胞検出による悪性腫瘍の検査方法および異常活性化細胞除去環流返血治療装置
GB201522398D0 (en) 2015-12-18 2016-02-03 Photocure As Device for photodynamic therapy
US12194098B2 (en) * 2017-06-21 2025-01-14 Photocure Asa Method for preparing a liquid pharmaceutical composition and device for use in such method
US20250188521A1 (en) 2022-03-10 2025-06-12 Singular Genomics Systems, Inc. Nucleic acid delivery scaffolds

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002009690A2 (en) * 2000-07-27 2002-02-07 Photocure Asa Pharmaceutical composition comprising a photochemotherapeutic agent and a mucoadhesive agent
US20060018956A1 (en) * 2002-01-23 2006-01-26 Geoffrey Lee Dermal application system for aminolevulinic acid-derivatives
US20090198173A1 (en) * 2006-04-27 2009-08-06 Lumicure Limited Light Emitting Device for use in Therapeutic and/or Cosmetic Treatment
WO2010026422A1 (en) * 2008-09-03 2010-03-11 Mmicure Limited Controlled light emitting apparatus

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4659096A (en) * 1995-01-30 1996-08-21 Angiomedics Ii Incorporated Photolytic drug delivery systems
CZ291132B6 (cs) 1995-03-10 2002-12-11 Photocure Asa Estery kyselin 5-aminolevulových a farmaceutický prostředek s jejich obsahem
GB2360459B (en) * 2000-03-23 2002-08-07 Photo Therapeutics Ltd Therapeutic light source and method
US6551346B2 (en) * 2000-05-17 2003-04-22 Kent Crossley Method and apparatus to prevent infections
GB0018528D0 (en) 2000-07-27 2000-09-13 Photocure Asa Compounds
GB0118251D0 (en) 2001-07-26 2001-09-19 Photocure Asa Method
US20030153590A1 (en) * 2001-08-14 2003-08-14 Oy Contral Pharma Ltd Method of treating alcoholism or alcohol abuse
EP1312353A1 (en) 2001-11-16 2003-05-21 Ecole Polytechnique Federale De Lausanne (Epfl) Method for hair removal
US20050085455A1 (en) * 2003-10-16 2005-04-21 Light Sciences Corporation Photodynamic therapy for local adipocyte reduction
CA2457214A1 (en) * 2004-02-06 2005-08-06 Qlt Inc. Photodynamic therapy for the treatment of acne
GB0406917D0 (en) 2004-03-26 2004-04-28 Photocure Asa Compounds
GB0424833D0 (en) 2004-11-10 2004-12-15 Photocure Asa Method
JP2008526418A (ja) 2005-01-18 2008-07-24 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ 放射線を放出するための電子制御されるカプセル
CA2602835A1 (en) * 2005-03-31 2006-10-05 Esther Mayer Probe device, system and method for photobiomodulation of tissue lining a body cavity
US20070260231A1 (en) * 2005-04-21 2007-11-08 Ondine International, Ltd. Optical probe for delivery of light
DE102006001736A1 (de) * 2006-01-13 2007-07-26 Margull, Matthias, Dipl.-Ing. Vorrichtung zur Applikation von monochromatischem Licht in Körperöffnungen
US8292935B2 (en) * 2006-09-12 2012-10-23 Bistitec Pharma Marketing Ltd Photonic device and method for treating cervical dysplasia
GB0724279D0 (en) * 2007-12-12 2008-01-23 Photocure Asa Use
GB0823472D0 (en) 2008-12-23 2009-01-28 Photocure Asa Product
GB0900461D0 (en) * 2009-01-12 2009-02-11 Photocure Asa Photodynamic therapy device
CN102458388B (zh) 2009-06-11 2016-09-28 光治疗Asa公司 半固体组合物及药物制品

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002009690A2 (en) * 2000-07-27 2002-02-07 Photocure Asa Pharmaceutical composition comprising a photochemotherapeutic agent and a mucoadhesive agent
US20060018956A1 (en) * 2002-01-23 2006-01-26 Geoffrey Lee Dermal application system for aminolevulinic acid-derivatives
US20090198173A1 (en) * 2006-04-27 2009-08-06 Lumicure Limited Light Emitting Device for use in Therapeutic and/or Cosmetic Treatment
WO2010026422A1 (en) * 2008-09-03 2010-03-11 Mmicure Limited Controlled light emitting apparatus

Also Published As

Publication number Publication date
US20130178787A1 (en) 2013-07-11
BR112013000613A2 (pt) 2016-06-28
ES2620780T3 (es) 2017-06-29
WO2012004399A1 (en) 2012-01-12
CA2804337A1 (en) 2012-01-12
JP5991970B2 (ja) 2016-09-14
EP2590714B1 (en) 2017-03-08
AU2011275695A1 (en) 2013-02-14
KR101842732B1 (ko) 2018-05-14
CN103118742A (zh) 2013-05-22
EP2590714A1 (en) 2013-05-15
JP2013532035A (ja) 2013-08-15
KR20130083436A (ko) 2013-07-22

Similar Documents

Publication Publication Date Title
AU2011275695B2 (en) Dry compositions and devices containing such dry compositions for use in photodynamic therapy or photodynamic diagnosis
KR101797780B1 (ko) 반고체 조성물 및 약제학적 제품
CA2708137A1 (en) Use of solid pharmaceutical products comprising 5-aminolevulinic acid
US20110293528A1 (en) Enema preparations and their use
WO2013053904A1 (en) Stent
CN103118742B (zh) 用于光动力学治疗或光动力学诊断的干燥组合物和含这种干燥组合物的装置
US20140276107A1 (en) Photodynamic diagnosis
AU2014200004B2 (en) Use of 5-aminolevulinic acid and derivatives in a solid form for photodynamic treatment and diagnosis
GB2546356A (en) Solid products and their use
HK1164163B (en) Semi-solid compositions and pharmaceutical products

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired